You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
義翹神州(301047.SZ)首日上市收漲68.41% 換手率50.15%
格隆匯 08-16 15:12
格隆匯8月16日丨“重組蛋白一哥”義翹神州(301047.SZ)今日首日上市,盤中一度漲104.82%報599.96元,最終收漲68.41%報493.32元,成交45.18億元,換手率50.15%,最新市值335億元。該股發行價格292.92元/股,超越石頭科技,刷新了A股史上的發行價最高紀錄。義翹神州主要從事重組蛋白、抗體、cDNA克隆、ELISA試劑盒等的研發與生產。作為新冠疫情受益的生物製藥企業,義翹神州2020年度業績暴增,招股書顯示,義翹神州2020年度營收15.96億元,較2019年增長782.77%,淨利潤11.28億元,同比增長超2996%,其中新冠病毒相關產品收入佔當期營業收入的比例為84%。值得關注的是,2020年,義翹神州以96.88%的毛利率超過了大白馬貴州茅台91.41%的毛利率。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account